GlaxoSmithKline bans political donations, alters spending rules on doctor training, consulting
TRENTON, N.J. (AP) — British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information.
The change follows similar moves by some major competitors — possibly concerned about proposed federal rules that could be tougher — and a ban Glaxo instituted this year on all corporate political contributions worldwide.
The key change announced Monday involves an end to funding educational programs run by commercial medical education and communication companies. Some have been found to help drug companies by ghostwriting research articles on their drugs for medical journals and getting respected academic researchers to claim to be the primary authors.